Clonitazene

Identification

Generic Name
Clonitazene
DrugBank Accession Number
DB01523
Background

Not Available

Type
Small Molecule
Groups
Experimental, Illicit
Structure
Weight
Average: 386.875
Monoisotopic: 386.150953707
Chemical Formula
C20H23ClN4O2
Synonyms
  • Clonitazene
External IDs
  • IDS-NC-002

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzimidazoles. These are organic compounds containing a benzene ring fused to an imidazole ring (five member ring containing a nitrogen atom, 4 carbon atoms, and two double bonds).
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Benzimidazoles
Sub Class
Not Available
Direct Parent
Benzimidazoles
Alternative Parents
Nitroaromatic compounds / Chlorobenzenes / N-substituted imidazoles / Aryl chlorides / Heteroaromatic compounds / Trialkylamines / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Azacyclic compounds / Organopnictogen compounds
show 3 more
Substituents
Allyl-type 1,3-dipolar organic compound / Amine / Aromatic heteropolycyclic compound / Aryl chloride / Aryl halide / Azacycle / Azole / Benzenoid / Benzimidazole / C-nitro compound
show 21 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
S90R21A2V2
CAS number
3861-76-5
InChI Key
GPZLDQAEBHTMPG-UHFFFAOYSA-N
InChI
InChI=1S/C20H23ClN4O2/c1-3-23(4-2)11-12-24-19-10-9-17(25(26)27)14-18(19)22-20(24)13-15-5-7-16(21)8-6-15/h5-10,14H,3-4,11-13H2,1-2H3
IUPAC Name
(2-{2-[(4-chlorophenyl)methyl]-5-nitro-1H-1,3-benzodiazol-1-yl}ethyl)diethylamine
SMILES
CCN(CC)CCN1C(CC2=CC=C(Cl)C=C2)=NC2=C1C=CC(=C2)[N+]([O-])=O

References

General References
Not Available
PubChem Compound
62528
PubChem Substance
46509015
ChemSpider
56301
ChEMBL
CHEMBL2104616
Wikipedia
Clonitazene

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)75.5 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility0.0111 mg/mLALOGPS
logP4.95ALOGPS
logP4.72Chemaxon
logS-4.5ALOGPS
pKa (Strongest Basic)9.6Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area64.2 Å2Chemaxon
Rotatable Bond Count8Chemaxon
Refractivity107.67 m3·mol-1Chemaxon
Polarizability41.9 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.9593
Caco-2 permeable-0.5265
P-glycoprotein substrateSubstrate0.751
P-glycoprotein inhibitor INon-inhibitor0.5101
P-glycoprotein inhibitor IIInhibitor0.8068
Renal organic cation transporterInhibitor0.5685
CYP450 2C9 substrateNon-substrate0.8435
CYP450 2D6 substrateNon-substrate0.7904
CYP450 3A4 substrateSubstrate0.6059
CYP450 1A2 substrateNon-inhibitor0.7552
CYP450 2C9 inhibitorNon-inhibitor0.8396
CYP450 2D6 inhibitorNon-inhibitor0.7485
CYP450 2C19 inhibitorNon-inhibitor0.6154
CYP450 3A4 inhibitorNon-inhibitor0.7558
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.842
Ames testAMES toxic0.7001
CarcinogenicityNon-carcinogens0.7208
BiodegradationNot ready biodegradable0.9964
Rat acute toxicity2.6223 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Strong inhibitor0.8752
hERG inhibition (predictor II)Inhibitor0.6342
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-187.15291
predicted
DeepCCS 1.0 (2019)
[M+H]+189.5109
predicted
DeepCCS 1.0 (2019)
[M+Na]+195.68834
predicted
DeepCCS 1.0 (2019)

Drug created at July 31, 2007 13:10 / Updated at February 21, 2021 18:51